Majmundar Laboratory
banner
majmundarlab.bsky.social
Majmundar Laboratory
@majmundarlab.bsky.social
Kidney Genetics Laboratory
@bostonchildrens.bsky.social @harvardmed.bsky.social

majmundarlab.com

Driven to discover, model and treat genetic kidney diseases.
Integrating genetic testing into kidney care starts with helping nephrologists build fluency in genetics. Recently gave two seminars at World Kidney Academy Genetic Kidney Disease Masterclass: core genetic concepts for nephrologists, and genetic testing in CKD of unclear etiology.
September 3, 2026 at 2:55 PM
Genetic testing in nephrology has exploded, creating opportunities but also challenges for providers and families. We started @bostonchildrens.bsky.social Kidney Genetics Clinic to address gaps in counseling and delivery. See our outcomes in Kidney360 @asnpublications.bsky.social: bit.ly/3SIhCF6
Real-World Outcomes of a Pediatric Kidney... : Kidney360
Background:Despite the growing role of genetic testing in pediatric kidney disease, translating genomic findings into clinical care remains...
bit.ly
September 2, 2026 at 2:54 PM
Honored to have given Grand Rounds at Boston Children's Hospital on clinical implementation of genetic testing and genetic mechanisms of glomerular disease. Excited to work at the intersection of rare disease genomics and pediatric kidney care. @bostonchildrens.bsky.social @harvardmed.bsky.social
July 10, 2026 at 5:43 AM
Thankful to contribute to the @kdigo.org FSGS Summit in New Orleans led by Co-Chairs Brad Rovin and Laura Mariani to consider genetic testing and its impacts in FSGS alongside colleagues Ana Onuchic-Whitford, John Sim, Nina Mann, Johannes Schlondorff.
May 20, 2026 at 5:16 AM
Appreciate the opportunity to speak on variants of uncertain significance (VUS) in kidney genetic testing @kidneycon.bsky.social 2026 in Little Rock. Thank you to @uamshealth.bsky.social, @arkanalabs.bsky.social, Drs. John Arthur and Shree Sharma.
May 20, 2026 at 4:57 AM
🔬 #PostdocOpening @majmundarlab.bsky.social
@bostonchildrens.bsky.social @harvardmed.bsky.social

Come join us to study genetic kidney disease in kids — NS/FSGS, podocytes, cell biology, disease modeling. Looking for a driven PhD or MD with cell bio, mouse, iPSC experience.

bit.ly/4sHFXaj
bit.ly
March 15, 2026 at 1:09 AM
Extremely proud of our MS thesis students presenting oral talks and posters on our lab's work at the Joint 44th PNRC Mtg & 52nd Miami Peds Neph Seminar! 🧬 🫘

@majmundarlab.bsky.social
@bostonchildrens.bsky.social
@harvardmed.bsky.social
March 14, 2026 at 6:06 PM
Congratulations to Florian Buerger, Nils Mertens, Camille Nicolas Frank, Friedhelm Hildebrandt, and co. on our paper out in @kireports.bsky.social! Happy I could make a small contribution to this in-depth study.

kireports.org/article/S246...

@bostonchildrens.bsky.social
@harvardmed.bsky.social
NPHS2 Revisited through 208 Cases and Podocin Complex Modeling
Steroid-resistant nephrotic syndrome (SRNS) is the leading cause of chronic glomerular disease in individuals under 25 years of age. Biallelic variants in NPHS2, encoding podocin, are the most common ...
kireports.org
February 27, 2026 at 4:50 PM
Sharing a exciting study by Howard Trachtman and colleagues in Lancet demonstrating efficacy of a targeted therapy for genetic FSGS. Exciting development and blueprint for tackling other genetic kidney diseases.

thelancet.com/journals/lancet/article/PIIS0140-6736(25)02255-X/abstract?rss=yes
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
BI 764198 lowered proteinuria and was well tolerated by participants in this trial. This is the first evidence of efficacy with a podocyte-targeted therapy in FSGS. Larger randomised controlled trials...
www.thelancet.com
January 31, 2026 at 8:05 PM
Reposted by Majmundar Laboratory
Predicting better lipids: In a cover-winning @natbiotech.nature.com paper, the Anderson & Langer Labs screened 1.6M lipids in silico to speed up successful designs for mRNA delivery to lungs. www.nature.com/articles/s41...
December 12, 2025 at 5:15 PM
Genes regulate kidney stones. In our recent editorial, Ken Saida and I review the evolving landscape of Mendelian genetics in KSD and discuss findings from a large cohort analysis in cJASN:
doi.org/10.2215/CJN....

@harvardmed.bsky.social @bostonchildrens.bsky.social
doi.org
December 11, 2025 at 3:30 PM
In our new @natcomms.nature.com study, we show that intergenic splicing of the NS disease gene/actin regulator NOS1AP is essential for kidney filter function via transcriptomic, proteomic, human genetic & mouse model studies.

@harvardmed.bsky.social @bostonchildrens.bsky.social

t.co/2xegr1OUlm
https://www.nature.com/articles/s41467-025-65663-6
t.co
December 11, 2025 at 3:20 PM